Mosaicism: The embryo as a target for induction of mutations leading to cancer and genetic disease
Authors:
- 1 January 1995
- journal article
- review article
- Published by Wiley in Environmental and Molecular Mutagenesis
- Vol. 25 (S2) , 21-29
Abstract
Mosaicism, the existence of “patches” of cells with a genetic constitution that differs from that of other cells of an organism, has been observed in both germinal and somatic tissues of several species, including humans. Mutational events occurring during early embryogenesis can give rise to an organism with a significant number of cells with the mutant genotype in one or more tissues. If this event occurs in a precursor of the germ cells, the mutation can be transferred to subsequent generations. In the F1 generation, this event will usually be perceived as a de novo germinal mutation rather than a transmitted variant allele, unless significant effort is directed toward detecting the mosaicism. Similarly, mutations in oncogenes and tumor‐suppressor genes in proliferating somatic cells can generate populations of cells that are at increased risk of transforming into tumor cells. The number of potential preneoplastic cells is larger when the mutagenic event occurs in early development than if it occurs in the mature adult. Experimental data confirm that treatment of the developing embryo or fetus with carcinogenic and mutagenic agents increases the cancer incidence in these animals and the frequency of mutations in the offspring of the animals that were exposed in utero. The available data are conclusive that the developing organism is at risk from exposure to mutagenic and carcinogenic agents. However, the data are insufficient to estimate the level of risk associated with exposures in utero, relative to either the background (spontaneous) level of risk or risk associated with similar exposures to the adult organism. Given the dynamics of cell division, it can be expected that the potential risk from exposure of the developing embryo is increased relative to the risk from adult exposure if the sensitivity of the individual cells to damage in the adult and the embryo are equivalent. It seems apparent that the potential risks of cancer and heritable disease following in utero exposure are sufficient to warrant additional attention. It is important to obtain data for estimating the relative contribution of in utero exposure to mutagenic and carcinogenic agents to the total health burden and for the subsequent development of appropriate regulations.Keywords
This publication has 33 references indexed in Scilit:
- Geographic Variation of p53 Mutational Profile in Nonmalignant Human LiverScience, 1994
- N-nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hras1 gene mutations.Proceedings of the National Academy of Sciences, 1994
- Working paper no. 5 Impact of the molecular spectrum of mutational lesions on estimates of germinal gene-mutation ratesMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1994
- The induction of recessive mutations in mouse primordial germ cells with N-ethyl-N-nitrosoureaMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1993
- Mechanisms of multistep carcinogenesis and carcinogen risk assessment.Environmental Health Perspectives, 1993
- Parental origin and germline mosaicism of deletions and duplications of the dystrophin gene: a European studyHuman Genetics, 1992
- The paternal genome in mouse zygotes is less sensitive to ENU mutagenesis than the maternal genomeMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1991
- Somatic origin of inherited haemophilia AHuman Genetics, 1990
- Ethylnitrosourea-induced mutations in vivo involving the Dolichos biflorus agglutinin receptor in mouse intestinal epitheliumMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1990
- Supermutagenicity of ethylnitrosourea in the mouse spot testMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1982